HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

butyloxycarbonyl-aspartyl-fluoromethyl ketone

Also Known As:

Boc-Asp-FMK; inhibitor BAF; zBocD-FMk

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Amino Acid Chloromethyl Ketones
    - butyloxycarbonyl-aspartyl-fluoromethyl ketone: 2

Experts

1.	Blomgren, Klas: 1 article (07/2003)
2.	Candé, Céline: 1 article (07/2003)
3.	Hagberg, Henrik: 1 article (07/2003)
4.	Hallin, Ulrika: 1 article (07/2003)
5.	Kroemer, Guido: 1 article (07/2003)
6.	Qiu, Lin: 1 article (07/2003)
7.	Wang, Xiaoyang: 1 article (07/2003)
8.	Zhu, Changlian: 1 article (07/2003)
9.	Dreyer, E B: 1 article (07/2000)
10.	Shindler, K S: 1 article (07/2000)

Related Diseases

1.	Ganglion Cysts (Ganglion) 07/14/2000 - "A general caspase inhibitor, BAF, prevented EDBA induced ganglion cell death. "
2.	Infarction (Infarctions) 07/01/2003 - "The number of AIF-positive nuclei showed a positive correlation with the infarct volume 72 h post-HI, and this was not changed by treating the animals with boc-Asp-fmk (BAF), a multicaspase inhibitor. "

Related Drugs and Biologics

1.	Caspases
2.	EDBA